OrganiGram
Biotechnology
Geron Corporation shares (NASDAQ:GERN) continue to rise today. The biopharmaceutical company focuses on cancer research, and today surged up to approximately 18.38%. The company released its fourth quarter and annual financial results and this press release on ... [Read]